X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69) 69
male (59) 59
female (51) 51
index medicus (49) 49
middle aged (49) 49
cardiac & cardiovascular systems (48) 48
aged (39) 39
adult (25) 25
stroke (25) 25
atrial fibrillation (24) 24
risk factors (23) 23
mortality (17) 17
myocardial infarction (16) 16
risk (16) 16
abridged index medicus (15) 15
medicine, general & internal (15) 15
double-blind method (14) 14
treatment outcome (14) 14
aged, 80 and over (12) 12
drug therapy (12) 12
management (12) 12
acute coronary syndromes (11) 11
analysis (11) 11
cardiology (11) 11
care and treatment (11) 11
catheter ablation (11) 11
hypertension (11) 11
patients (11) 11
cardiovascular disease (10) 10
electrocardiography (10) 10
endocrinology & metabolism (10) 10
medical and health sciences (10) 10
medicin och hälsovetenskap (10) 10
prevention (10) 10
therapy (10) 10
atrial fibrillation - drug therapy (9) 9
cerebral infarction (9) 9
cholesterol (9) 9
myocardial-infarction (9) 9
acute coronary syndrome (8) 8
anticoagulation (8) 8
brazil (8) 8
cardiovascular diseases (8) 8
clinical medicine (8) 8
death (8) 8
diabetes (8) 8
efficacy (8) 8
heart attacks (8) 8
hemorrhage (8) 8
klinisk medicin (8) 8
outcomes (8) 8
risk assessment (8) 8
stroke - prevention & control (8) 8
time factors (8) 8
warfarin (8) 8
alirocumab (7) 7
anticoagulants (7) 7
cardiac and cardiovascular systems (7) 7
follow-up studies (7) 7
health risk assessment (7) 7
heart diseases (7) 7
ischemia (7) 7
kaplan-meier estimate (7) 7
kardiologi (7) 7
medicine & public health (7) 7
patient outcomes (7) 7
peripheral vascular disease (7) 7
prevalence (7) 7
prospective studies (7) 7
usage (7) 7
anticoagulants - therapeutic use (6) 6
arrhythmia (6) 6
clinical trials as topic (6) 6
coronary angiography (6) 6
coronary heart disease (6) 6
diseases of the circulatory system (6) 6
drug therapy, combination (6) 6
fibrillation (6) 6
guidelines (6) 6
heart attack (6) 6
statins (6) 6
acute coronary syndrome - drug therapy (5) 5
angina (5) 5
angina pectoris (5) 5
angiography (5) 5
anticoagulants - adverse effects (5) 5
antiplatelet therapy (5) 5
association (5) 5
atherosclerosis (5) 5
atrial fibrillation - complications (5) 5
bleeding (5) 5
body mass index (5) 5
cardiovascular (5) 5
cardiovascular diseases - mortality (5) 5
case-control studies (5) 5
complications (5) 5
complications and side effects (5) 5
coronary artery disease (5) 5
diagnosis (5) 5
disease (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Sawhney, Jitendra PS and Kothiwale, Veerappa A and Bisne, Vikas and Durgaprasad, Rajashekhar and Jadhav, Praveen and Chopda, Manoj and Vanajakshamma, Velam and Meena, Ramdhan and Vijayaraghavan, Govindan and Chawla, Kamaldeep and Allu, Jagan and Pieper, Karen S and John Camm, A and Kakkar, Ajay K and Kakkar, Ajay K and Bassand, Jean-Pierre and John Camm, A and Fitzmaurice, David A and Goldhaber, Samuel Z and Goto, Shinya and Haas, Sylvia and Hacke, Werner and Mantovani, Lorenzo G and Misselwitz, Frank and Pieper, Karen S and Turpie, Alexander G.G and van Eickels, Martin and Verheugt, Freek W.A and Kayani, Gloria and Fox, Keith A.A and Gersh, Bernard J and Luciardi, Hector Lucas and Gibbs, Harry and Brodmann, Marianne and Cools, Frank and Barretto, Antonio Carlos Pereira and Connolly, Stuart J and Spyropoulos, Alex and Eikelboom, John and Corbalan, Ramon and Hu, Dayi and Jansky, Petr and Nielsen, Jørn Dalsgaard and Ragy, Hany and Raatikainen, Pekka and Le Heuzey, Jean-Yves and Darius, Harald and Keltai, Matyas and Kakkar, Sanjay and Sawhney, Jitendra Pal Singh and Agnelli, Giancarlo and Ambrosio, Giuseppe and Koretsune, Yukihiro and Sánchez Díaz, Carlos Jerjes and Ten Cate, Hugo and Atar, Dan and Stepinska, Janina and Panchenko, Elizaveta and Lim, Toon Wei and Jacobson, Barry and Oh, Seil and Viñolas, Xavier and Rosenqvist, Marten and Steffel, Jan and Angchaisuksiri, Pantep and Oto, Ali and Parkhomenko, Alex and Al Mahmeed, Wael and Fitzmaurice, David and Hu, D.Y and Chen, K.N and Zhao, Y.S and Zhang, H.Q and Chen, J.Z and Cao, S.P and Wang, D.W and Yang, Y.J and Li, W.H and Yin, Y.H and Tao, G.Z and Yang, P and Chen, Y.M and He, S.H and Wang, Ying and Wang, Yong and Fu, G.S and Li, X and Wu, T.G and Cheng, X.S and Yan, X.W and Zhao, R.P and Chen, M.S and Xiong, L.G and Chen, P and Jiao, Y and Guo, Y and Xue, L and Wang, F.Z and Li, H and Yang, Z.M and ... and GARFIELD-AF Investigators
Indian Heart Journal, ISSN 0019-4832, 11/2018, Volume 70, Issue 6, pp. 828 - 835
The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing... 
Arrhythmia | GARFIELD-AF | Atrial fibrillation | Anticoagulant therapy | Clinical and Preventive Cardiology
Journal Article
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 38, pp. 2882 - 2889A
The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the... 
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article